Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping

One promising approach for the gene therapy of Duchenne muscular dystrophy (DMD) is exon skipping. When thinking of possible intervention on human, it is very crucial to identify the most appropriate antisense sequences able to provide the highest possible skipping efficiency. In this article, we co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Incitti, Tania, De Angelis, Fernanda G, Cazzella, Valentina, Sthandier, Olga, Pinnarò, Chiara, Legnini, Ivano, Bozzoni, Irene
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2010
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956936/
https://ncbi.nlm.nih.gov/pubmed/20551908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.123
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi